Welcome to our dedicated page for Cutera news (Ticker: CUTR), a resource for investors and traders seeking the latest updates and insights on Cutera stock.
Cutera Inc (CUTR) is a global leader in medical aesthetics, pioneering advanced laser systems for skin treatments and body contouring. This page serves as the definitive source for official company announcements, financial disclosures, and technology developments.
Access real-time updates on earnings reports, FDA clearances, product launches, and strategic partnerships. Investors and practitioners alike rely on this centralized hub for tracking innovations in energy-based aesthetic devices and corporate milestones.
Our curated news feed includes clinical study results, regulatory updates, and market expansion announcements. Stay informed about CUTR's advancements in ND:YAG technology and international service network developments through verified primary sources.
Bookmark this page for streamlined access to CUTR's evolving position in the $6B medical aesthetics sector. Check regularly for critical updates affecting treatment protocols, device safety profiles, and corporate financial health.
Cutera, Inc. (NASDAQ: CUTR) reported strong financial results for Q3 2021, with revenue of $57.4 million, a 47% increase year-over-year. Key growth drivers included capital equipment revenue of $32.2 million (up 33%) and recurring revenue of $25.2 million (up 68%). Notably, skincare revenue rose 117% to $14.8 million. Gross margin improved to 58.2%. Although the company experienced a net loss of $1.4 million, Adjusted EBITDA more than doubled to $5.1 million. Based on Q3 performance, Cutera raised its full-year revenue guidance to $224-$228 million.
Cutera, Inc. (CUTR) will report its third-quarter financial results on November 3, 2021, after market close. Management will host a conference call at 1:30 p.m. PT to discuss the results. Interested parties can join by dialing 1-877-705-6003 domestically or +1-201-493-6725 internationally, referencing Conference ID 13723851. The call will also be available via webcast on Cutera’s website, with a replay accessible approximately one hour post-call.
Cutera, Inc. (NASDAQ: CUTR), a provider of laser and energy-based aesthetic systems, announced that CEO Dave Mowry will participate in a virtual fireside chat at the Cantor Fitzgerald Global Healthcare Conference. The event is scheduled for 1:20 p.m. ET on Tuesday, September 28, 2021. A live webcast will be available in the Investors section of Cutera's website and will also be accessible for replay post-event. Cutera has been developing innovative products since 1998, supporting practitioners in providing safe aesthetic treatments.
Cutera, Inc. (NASDAQ: CUTR) reported a strong financial performance for Q2 2021, with revenues of $58.6 million, a 122% increase year-over-year. Key segments included capital equipment revenue of $35.6 million (up 129%) and recurring revenue of $23.0 million (up 113%). Gross margin improved to 57.7%, a 13.6-point increase. Adjusted EBITDA rose to $6.8 million from a loss of $3.5 million last year. For 2021, Cutera projects revenue between $215 million and $221 million, reflecting a 46% to 50% increase over 2020.
Cutera, Inc. (Nasdaq: CUTR) announced it will report its second quarter 2021 financial results on August 4, 2021, after market close. Management will discuss these results in a conference call at 1:30 p.m. PT (4:30 p.m. ET) on the same day. Participants can join by calling 1-877-705-6003 (domestic) or +1-201-493-6725 (international), using Conference ID: 13721584. The call will also be accessible via a webcast on Cutera's Investor Relations website.
Cutera, Inc. (NASDAQ: CUTR) has renewed its exclusive distribution agreement with ZO Skin Health for skincare products in Japan, effective June 15, 2021, for an initial term of three years. This partnership aims to enhance the ZO skincare business while expanding Cutera's market presence in Japan. CEO Dave Mowry expressed satisfaction with the continued collaboration, emphasizing mutual growth opportunities over the next several years.
Cutera has appointed Sheila Hopkins to its Board of Directors, effective immediately. Chairman J. Daniel Plants praised her strategic capabilities, essential for Cutera's growth phase. CEO Dave Mowry expressed optimism about her commercial experience, beneficial for expanding Cutera's global operations. Hopkins has prior board experience and has held executive roles at Bausch + Lomb and Colgate-Palmolive. With her addition, Cutera aims to strengthen its position in the aesthetic systems market.
Cutera, a leader in energy-based aesthetic systems, will present at the Virtual UBS Global Healthcare Conference on May 26, 2021, at 3:00 pm ET. CEO Dave Mowry will lead the presentation, which will be available via webcast on the company's Investor Relations page. Based in Brisbane, California, Cutera has been providing innovative aesthetic solutions since 1998, enabling practitioners to deliver safe and effective treatments. For more details, visit www.cutera.com.
Cutera, Inc. (NASDAQ: CUTR) announces the resignation of President and COO Jason Richey, effective May 4, 2021, to pursue other opportunities. Richey will assist during the transition until May 31, 2021. CEO Dave Mowry will take on COO responsibilities temporarily. The company has engaged an executive search firm to find a new Chief Commercial Officer to steer growth. Both Mowry and Board Chairman J. Daniel Plants praised Richey's contributions during his tenure, highlighting his leadership during challenging times.
FAQ
What is the current stock price of Cutera (CUTR)?
What is the market cap of Cutera (CUTR)?
